Update on Cystic Fibrosis-Related Bone Disease: A Special Focus on Children

Paediatric Respiratory Reviews

Volumn 10, Issue 3, 2009, Pages 134-142

  Sermet Gaudelus, Isabelle ^a   Castanet, Mireille ^a   Retsch Bogart, George ^b   Aris, Robert M ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphosphonates; Bone mineralization; Cystic fibrosis; Dual energy X ray absorptiometry; Vitamin D

Indexed keywords

ALENDRONIC ACID; ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; ERGOCALCIFEROL; GLUCOCORTICOID; PAMIDRONIC ACID; RECOMBINANT GROWTH HORMONE; SEX HORMONE; VITAMIN D; VITAMIN K GROUP; ZOLEDRONIC ACID;

ADOLESCENCE; ADULTHOOD; BONE DENSITY; BONE DISEASE; BONE MASS; BONE MINERALIZATION; BONE PAIN; CHILD; CHILD GROWTH; CHILDHOOD; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; FEVER; HORMONE SYNTHESIS; HUMAN; IMMOBILIZATION; INFLAMMATION; MALNUTRITION; OSTEOPENIA; OSTEOPOROSIS; PHLEBITIS; PREVALENCE; PRIORITY JOURNAL; PUBERTY; RECOMMENDED DRUG DOSE; REVIEW; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

ADULT; BONE DENSITY; BONE DISEASES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; PUBERTY; VITAMIN K;

EID: 67849086662     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2009.05.001     Document Type: Review

References (98)

1. Rowe S., Miller S., and Sorscher E.J. Cystic Fibrosis. N Engl J Med 352 (2005) 1992-2001
2. Mischler E.H., Chesney P.J., Chesney R.W., and Mazess R.B. Demineralization in cystic fibrosis detected by direct photon absortiometry. Am J Dis Child 133 (1979) 632-635
3. Conway S.P., Morton A.M., Oldroyd B., et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55 (2000) 798-804
4. Aris R.M., Merkel P.A., Bachrach L.K., et al. Consensus conference report : guide to bone health and disease in cystic fibrosis. J Clin Endocr Metabol 90 (2005) 1888-1896
5. Aris R.M., Renner J.B., Winders A.D., et al. Increased fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Int Med 128 (1998) 186-193
6. Aris R.M., Neuringer I.P., Weiner M.A., Egan T.M., and Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 109 (1996) 1176-1183
7. Henderson R.C., and Madsen C.D. Bone mineral content and body composition in children and young adults with cystic fibrosis. Ped Pulmonol 27 (1999) 80-84
8. Haworth C.S., Selby P.L., Webb A.K., et al. Low bone mineral density in adults with cystic fibrosis. Thorax 54 (1999) 961-967
9. Elkin S.L., Fairney A., Burnett S., et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12 (2001) 366-372
10. Aris R.M., Lester G.E., Caminiti M., et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 169 (2004) 77-82
11. Papaioannou A., Kennedy C.C., Freitag A., et al. Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest 134 (2008) 794-800
12. Chapman I., Greville H., Ebeling P.R., et al. Intravenous zoledronate improves bone density in adults with cystic fibrosis. Clin Endocrinol (Oxf) (2008) Epub ahead of print
13. Bhudhikanok G.S., Lim J., Marcus R., Harkins A., Moss R.B., and Bachrach L.K. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics 97 (1996) 103-111
14. Gronowitz E., Garemo M., Lindblad A., Mellström D., and Strandvik B. Decreased bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr 92 (2003) 688-693
15. Ujhelyi R., Treszl A., Vasarhelyi B., et al. Bone mineral density acquisition in children and young adults with cystic fibrosis: a follow-up study. J Ped Gastroenterol Nutr 38 (2004) 401-406
16. Bianchi M.L., Romano G., Saraifoger S., Costantini D., Limonta C., and Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 21 (2006) 388-396
17. Sermet-Gaudelus I., Souberbielle J.C., Ruiz J.C., et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Car Med 175 (2007) 951-957
18. Grey V., Atkinson S., Drury D., et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 canadian centers. Pediatrics 122 (2008) 1014-1020
19. Laursen E.M., Molgaard C., Michaelsen K.F., Koch C., and Müller J. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 81 (1999) 235-240
20. Mortensen L.A., Chan G.M., Alder S.C., and Marshall B.C. Bone mineral status in prepubertal children with cystic fibrosis. J Pediatr 136 (2000) 648-652
21. Sood M., Hambleton G., Super M., Fraser W.D., Adams J.E., and Mughal M.Z. Bone status in cystic fibrosis. Arch Dis Child 84 (2001) 516-520
22. Hardin D.S., Arumugam R., Seilheimer D.K., LeBlanc A., and Ellis K.J. Normal bone mineral density in cystic fibrosis. Arch Dis Child 84 (2001) 363-368
23. Buntain H.M., Greer R.M., Schluter P.J., et al. Bone mineral density in australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 59 (2004) 149-155
24. Kelly A., Schall J.I., Stallings V.A., and Zemel B.S. Deficits in bone mineral contents in children and adolescents with cystic fibrosis are related to height deficits. J Clin Densitom 11 (2008) 581-589
25. Conway S.P., Oldroyd B., Brownlee K.G., and Truscott J.G. A cross-sectional study of bone mineral density in children and adolescents attending a cystic fibrosis centre. J Cyst Fibr 7 (2008) 469-476
26. Rovner A.J., Zemel B.S., Leonard M.B., Schall J.I., and Stallings V.A. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents. J Pediatr 147 (2005) 327-331
27. Buntain H.M., Schluter P.J., Bell S.C., et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 61 (2006) 146-154
28. Bhudhikanok G.S., Wang M.C., Marcus R., Harkins A., Moss R.B., and Bachrach L.K. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 133 (1998) 18-27
29. Henderson R.C., and Madsen C. Bone density in children and adolescents with cystic fibrosis. J Pediatr 128 (1996) 28-34
30. Gronowitz E., Mellström D., and Strandvik B. Normal annual increase of bone mineral density during two years in patients with cystic fibrosis. Pediatrics 114 (2004) 435-442
31. Henderson R.C., and Specter B.B. Kyphosis and fractures in children and young adukts with cystic fibrosis. J pediatr 125 (1994) 208-212
32. Bachrach L.K., Loutit C.W., and Moss R.B. Osteopenia in adults with cystic fibrosis. Am J Med 96 (1994) 27-34
33. Donovan D.S., Papadopoulos A., Staron R.B., et al. Bone mass and vitamin D deficiency in adults with advanced Cystic Fibrosis lung disease. Am J Respir Crit Care Med 157 (1998) 1892-1899
34. Papaioannou A., Kennedy C.C., Freitag A., et al. Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskelet Disord 9 (2008) 125
35. Rossini M., Viapiana O., Del Marco A., de Terlizzi F., Gatti D., and Adami S. Quantitative ultrasound in adults with cystic fibrosis: correlation with bone mineral density and risk of vertebral fractures. Calcif Tissue Int 80 (2007) 44-49
36. Saggese G., Baroncelli G.I., and Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab 16 (2002) 53-64
37. Buntain H.M., Greer R.M., Wong J.C., et al. Pubertal development and its influence on bone mineral density in Australian children and adolescents with cystic fibrosis. J Paediatr Child Health 41 (2005) 317-322
38. Byard P.J. The adolescent growth spurt in children with cystic fibrosis. Ann Hum Biol 21 (1994) 229-240
39. Johannesson M., Gottlieb C., and Hjelte L. Delayed puberty in girls with cystic fibrosis despite good clinical status. Pediatrics 99 (1997) 29-34
40. Arrigo T., De Luca F., Lucanto C., et al. Nutritional, glycometabolic and genetic factors affecting menarcheal age in cystic fibrosis. Diabetes Nutr Metab 17 (2004) 114-119
41. Jin R., Hodges C.A., Drumm M.L., and Palmert M.R. The Cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice. J Med Genet 43 (2006) e29
42. Ionescu A.A., Evans W.D., Pettit R.J., Nixon L.S., Stone M.D., and Shale D.J. Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis. Chest 124 (2003) 2220-2228
43. Fricke 0, Schoenau E. The "functional mucle-bone unit": probing the relevance of mechanical signals for bone development in children and adolescents. Growth Horm IGF Res 2007; 17: 1-9.
44. Kawai M., and Rosen C.J. Insulin-like growth factor-I and bone: lessons from mice and men. pediatr Nephrol (2008) Epub Ahead of Print
45. Gronowitz E., Mellstrom D., and Strandvik B. Serum phospholipids fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis. Br J Nutr 95 (2006) 1159-1165
46. Gronowitz E., Lorentzon M., Ohlsson C., Mellström D., and Strandvik B. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br J Nutr 99 (2008) 160-167
47. Hind K., Truscott J.G., and Conway S.P. Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercice for bone health in children with cystic fibrosis. J Cyst Fibr 7 (2008) 270-276
48. Dodd J.D., Barry S.C., Barry R.B., Cawood T.J., McKenna M.J., and Gallagher C.G. Bone mineral density in cystic fibrosis: benefit of exercise capacity. J Clin Densitom 11 (2008) 537-542
49. Hillman L.S., Cassidy J.T., Popescu M.F., Hewett J.E., Kyger J., and Robertson J.D. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol 43 (2008) 772-780
50. Aris R.M., Lester G.E., Dingman S., and Ontjes D.A. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int 10 (1999) 102-108
51. Schulze K.J., O'Brien K.O., Germain-Lee E.L., Baer D., Leonard A.L.R., and Rosenstein B.R. Endogenous fecal losses of calcium compromise calcium balance in pancreatic-insufficient girls with cystic fibrosis. J Pediatr 143 (2003) 765-771
52. Turner M., Goldwater D., and David J. Oxalate and calcium excretion in cystic fibrosis. Arch Dis Child 83 (2000) 244-247
53. Schulze K.J., Cutchins C., Rosenstein B.J., Germain-Lee E.L., and O'Brien K.O. Calcium acquisition rates do not support age-appropriate gains in total body mineral content in prepuberty and late puberty in girls with cystic fibrosis. Osteoporos Int 17 (2006) 731-740
54. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
55. Stephenson A., Brotherwood M., Robert R., Atenafu E., Corey M., and Tullis E. Cholecalciferol significantly increases 25-dihydroxyvitaminD concentrations in adults with cystic fibrosis. Am J Clin Nutr 85 (2007) 1307-1311
56. Greer R.M., Buntain H.M., Potter J.M., et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporos Int 14 (2003) 404-411
57. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
58. Wolfenden L.L., Judd S.E., Shah R., Sanyal R., Ziegler T.R., and Tangpricha V. Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinl (Oxf) 69 (2008) 374-381
59. Lark R.K., Lester G.E., Ontjes D.A., et al. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 73 (2001) 602-606
60. Omdahl J., Morris H., and May B. Hydroxylase enzymes of the vitamin D pathway: expression, function and regulation. Ann Rev Nutr 22 (2002) 139-166
61. Aris R.M., Ontjes D.A., Brown D.A., Chalermskulrat W., Neuringer I., and Lester G.E. Carboxylated osteocalcin levels in cystic fibrosis. Am J Respir Crit Care Med 168 (2003) 1129
62. Fewtrell M.S., Benden C., Williams J.E., et al. Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J Cyst Fibr 7 (2008) 307-312
63. Conway S.P., Wolfe S.P., Brownlee K.G., et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 115 (2005) 1325-1331
64. Grey A.B., Ames R.W., Matthews R.D., and Reid I.R. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 48 (1993) 589-593
65. Aris R.M., Ontjes D.A., Buell H.E., et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 13 (2002) 151-157
66. Aris R., Stephens A., Ontjes D., et al. Adverse alterations in bone metabolism are associated with lung infection in cystic fibrosis adults. Am J Respir Crit Care Med 162 (2000) 1674-1678
67. Manolagas S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332 (1995) 305-311
68. Jacquot J., Tabary O., and Clement A. Hyperinflammation in airways of cystic fibrosis patients: what's new?. Expert Rev Mol Diagn. 8 (2008) 359-363
69. Haworth C.S., Selby P.L., Webb A.K., et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 59 (2004) 613-617
70. Shead E.F., Haworth C.S., Gunn E., Bilton D., Scott M.A., and Compston J.E. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 174 (2006) 306-311
71. Aris R.M., Lester G.E., Renner J.B., et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 162 (2000) 941-946
72. Shane E., Papadopoulos A., Staron R.B., et al. Bone loss and fracture after lung transplantation. Transplantation 68 (1999) 220-227
73. Dif F., Marty C., Baudoin C., de Vernejoul M.C., and Levi G. Severe osteopenia in CFTR-null mice. Bone 35 (2004) 595-603
74. Haston C.K., Li W., Li A., Lafleur M., and Henderson J.E. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med 177 (2008) 309-315
75. Pashuck T.D., Franz S.E., Altman M.K., et al. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr Res (2008) Epub Ahead of Print
76. Shead E.F., Haworth C.S., Condliffe A.M., McKeon D.J., Scott M.A., and Compston J.E. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 62 (2007) 650-651
77. Clines G.A., Kingsley L.A., McKibbin C.R., Gabriel S.E., and Aris R.M. CF bone disease: Is mutant CFTR really the culprit?. Ped Pulmonology 30 (Suppl) (2007) 188-189
78. Raisz L.G. Screening for osteoporosis. N Engl J Med 353 (2005) 164-171
79. Schoenau E., Land C., Stabrey A., Remer T., and Kroke A. The bone mass concept: problems in short stature. European J Endocrinol 151 (2004) S87-S91
80. Fewtrell M.S., and On behalf of the british paediatric and adolescent bone group. Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child 88 (2003) 795-798
81. Sermet-Gaudelus I., Nove-Josserand R., Loeille G.A., et al. Recommendations for the management of bone demineralization in cystic fibrosis. Arch Pediatr 15 (2008) 301-312
82. MacKelvie K.J., Petit M.A., Khan K.M., Beck T.J., and McKay H.A. Bone mass and structure are enhanced following a 2-year randomised controlled trial of exercise in prepubertal boys. Bone 34 (2004) 755-764
83. Frangolias D.D., Paré P.D., Kendler D.L., Davidson A.G., Wong L., Raboud J., and Wilcox P.G. Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibr 2 (2003) 163-170
84. Britto M.T., Garrett J.M., Konrad T.R., Majure J.M., and Leigh M.W. Comparison of physical activity in adolescents with cystic fibrosis versus age-matched controls. Pediatr Pulmonol 30 (2000) 86-91
85. Moshang T., and Holsclaw D.S. Menarchal determinants in cystic fibrosis. Am J Dis Child 134 (1980) 1139-1142
86. Landon C., and Rosenfeld R.G. Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child 138 (1984) 388-391
87. Boyle M.P., Noschese M.L., Watts S.L., Davis M.E., Stenner S.E., and Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 172 (2005) 212-217
88. Wanner T.J., Lechtzin N., Davis M.E., et al. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in adults with cystic fibrosis. Ped Pulmonol 29 (Suppl) (2006) 392
89. Brown S., Ontjes D., Lark R., et al. Short term calcitriol administration improves calcium homeostasis in adults with CF. Osteoporos Int 14 (2003) 442-449
90. Gronowitz E., Larko O., Gilljam M., et al. Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis. Acta Paediatr 94 (2005) 547-552
91. Calcium requirements of infants, children and adolescents. American Academy of Pediatrics. Committee on Nutrition. Pediatrics 1999; 104: 1152-57.
92. Nicolaidou P., Stavrinadis I., Loukou I., et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 165 (2006) 540-545
93. Drury D., Grey V.L., Ferland G., Gundberg C., and Lands L.C. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibr 7 (2008) 457-459
94. Hardin D.S., Ahn C., Prestidge C., Seilheimer D.K., and Ellis K.J. Growth hormone improves bone mineral content in children with cystic fibrosis. J Pediatr Endocrinol Metab 18 (2005) 589-595
95. Hardin D.S., Adams-Huet B., Brown D., et al. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. J Clin Endocrinol Metab 91 (2006) 4925-4929
96. Glorieux F.H., Bishop N.J., Plotkin H., et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339 (1998) 947-952
97. Haworth C.S., Selby P.L., Adams J.E., Mawer E.B., Horrocks A.W., and Webb A.K. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 56 (2001) 314-316
98. Brenckmann C., Papaioannou A., Freitag A., Hennessey R., Hansen S., Ioannidis G., et al. Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study. BMC Musculoskelet Disord 4 (2003) 13